Michael McMullen - Agilent Technologies CEO

A -  USA Stock  

USD 151.46  1.51  1.01%

  CEO
Mr. Michael R. McMuller is President, Chief Executive Officer, Director of Agilent Technologies, Inc. Mr. McMullen has served as our Chief Executive Officer since March 2015 and as President since September 2014. From September 2014 to March 2015 he also served as our Chief Operating Officer. From September 2009 to September 2014 he served as Senior Vice President, Agilent and President, Chemical Analysis Group. Prior to that, he served in various capacities for Agilent including as our Vice President and General Manager of the Chemical Analysis Solutions Unit of the Life Sciences and Chemical Analysis Group and as Country Manager for our China, Japan and Korea Life Sciences and Chemical Analysis Group. Prior to that, Mr. McMullen served as the Controller for the HewlettPackard Company and Yokogawa Electric Joint Venture from July 1996 to March 1999. Since September 2018, Mr. McMullen has served as a member of the Board of Directors of Coherent, Inc. r. McMullen has broad and deep experience with the company and its businesses having been an employee of the company and its predecessor, HewlettPackard, for over 20 years. During the course of his career, he has developed considerable expertise in, and indepth knowledge of, our businesses from the perspective of an individual contributor and at numerous levels of management. This perspective gives valuable insight to our board.
Age: 58  CEO Since 2015      
408 345-8474  www.agilent.com

Michael McMullen Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael McMullen against Agilent Technologies stock is an integral part of due diligence when investing in Agilent Technologies. Michael McMullen insider activity provides valuable insight into whether Agilent Technologies is net buyers or sellers over its current business cycle. Note, Agilent Technologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Agilent Technologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Agilent Technologies Management Efficiency

Agilent Technologies has return on total asset of 7.82 % which means that for every 100 dollars spent on asset, it generated profit of $7.82. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 19.31 %, implying that it made 19.31 on every $100 invested by shareholders. Agilent Technologies management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Investment is expected to grow to 10.71. The current year Return on Average Assets is expected to grow to 0.07. Agilent Technologies Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 3.07 Billion. The current year Revenue to Assets is expected to grow to 0.68, whereas Total Assets are forecasted to decline to about 8.5 B.
The company has accumulated 3.12 B in total debt with debt to equity ratio (D/E) of 0.65, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.96, which is considered satisfactory as compared to similar companies.
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Similar Executives

Found 10 records

CEO Since

James BoyleLaboratory Corp
N/A
Paul KirchgraberLaboratory Corp
2019
Gary HuffLaboratory Corp
2017
Kevin SayerDexcom
2018
Yue DengGlobal Cord Blood
N/A
Deborah TannerLaboratory Corp
2015
Adam SchechterLaboratory Corp
2019
Rui ArashiyamaGlobal Cord Blood
N/A
Helmy EltoukhyGuardant Health
2017
John RatliffLaboratory Corp
2019
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 16500 people. Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Blvd., Santa Clara, CA 95051, United States and employs 16,500 people. Agilent Technologies is listed under Measuring and Control category by Fama And French industry classification.

Agilent Technologies Leadership Team

Elected by the shareholders, the Agilent Technologies' board of directors comprises two types of representatives: Agilent Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilent. The board's role is to monitor Agilent Technologies' management team and ensure that shareholders' interests are well served. Agilent Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilent Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Padraig McDonnell, Senior Vice President and Presidentident - Agilent CrossLab Group
Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President - Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President - Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Allison Ballmer, Vice President - Strategy and Corporate Development
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President, Agilent and President - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President of Human Resources and Global Communications
Susan Rataj, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Katharine Knobil, Chief Medical Officer.
Boon Koh, Non-Executive Independent Chairman of the Board
Robert Herbold, Independent Director

Agilent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilent Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Agilent Technologies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Pair Trading with Agilent Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agilent Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will appreciate offsetting losses from the drop in the long position's value.

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.